CANNONE, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 1.241
AS - Asia 577
EU - Europa 569
OC - Oceania 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.394
Nazione #
US - Stati Uniti d'America 1.238
CN - Cina 415
IE - Irlanda 277
SE - Svezia 131
TR - Turchia 69
SG - Singapore 63
IT - Italia 40
DE - Germania 37
FI - Finlandia 24
BE - Belgio 14
TW - Taiwan 13
IN - India 11
GB - Regno Unito 9
FR - Francia 8
NL - Olanda 6
PL - Polonia 4
NZ - Nuova Zelanda 3
RO - Romania 3
UA - Ucraina 3
AT - Austria 2
CA - Canada 2
EG - Egitto 2
MD - Moldavia 2
NO - Norvegia 2
VN - Vietnam 2
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ES - Italia 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
LU - Lussemburgo 1
OM - Oman 1
PT - Portogallo 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
Totale 2.394
Città #
Dublin 276
Chandler 264
Beijing 133
Ann Arbor 128
Ashburn 116
Dearborn 88
Nanjing 81
Izmir 69
Princeton 61
Wilmington 42
Houston 40
Singapore 30
Shanghai 28
Woodbridge 28
Kunming 27
Helsinki 24
Bremen 23
Seattle 21
Nanchang 19
Fremont 18
Shenyang 16
Brussels 14
Hebei 14
Jiaxing 14
Taipei 13
Parma 12
Tianjin 12
Boardman 11
Changsha 11
Hefei 11
Jinan 10
San Mateo 9
Norwalk 8
Redmond 8
Guangzhou 7
Rockville 7
Pune 6
Borås 5
Des Moines 5
Milan 5
Amsterdam 4
Los Angeles 4
New York 4
Warsaw 4
Washington 4
Xian 4
Chengdu 3
Nürnberg 3
Wenzhou 3
Bergamo 2
Cairo 2
Como 2
Dong Ket 2
Falls Church 2
Fuzhou 2
Huzhou 2
Hyderabad 2
Jacksonville 2
Ningbo 2
Oderzo 2
Redwood City 2
Senigallia 2
Suri 2
Taiyuan 2
Tetchea 2
Trezzano Sul Naviglio 2
Vienna 2
Apo 1
Arconate 1
Auckland 1
Baotou 1
Bologna 1
Bristol 1
Chongqing 1
Cincinnati 1
Clearwater 1
Edinburgh 1
Enschede 1
Esslingen am Neckar 1
Fairfield 1
Forest City 1
Frankfurt am Main 1
Grafing 1
Haikou 1
Hangzhou 1
Heathfield 1
Jinhua 1
Kish 1
Langfang 1
Las Vegas 1
Latisana 1
Lisbon 1
Luxembourg 1
Madrid 1
Monasterevin 1
Nashville 1
Nottingham 1
Oslo 1
Paraparaumu 1
Pavia 1
Totale 1.816
Nome #
Atrial natriuretic peptide: A molecular target of novel therapeutic approaches to cardio-metabolic disease 113
NT-proBNP, race and endothelial function in the Multi-Ethnic Study of Atherosclerosis 85
Concurrent heterozygous Von-Hippel-Lindau and transmembrane-protein-127 gene mutation causing an erythropoietin-secreting pheochromocytoma in a normotensive patient with severe erythrocytosis 78
Electrolyte Disorders Induced by Antineoplastic Drugs 65
Posterior reversible encephalopathy syndrome in an oncological normotensive patient: Evidence for a pathogenic role of concomitant low magnesium serum levels and chemotherapy treatment 55
PRESENCE OF A NATRIURETIC PEPTIDE DEFICIENCY STATE AMONGST PATIENTS DIAGNOSED WITH HYPERTENSION 54
Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: A 9-year follow-up study 51
DIFFERENTIAL REGULATION OF CIRCULATING CARDIAC NATRIURETIC PEPTIDES IN HUMAN ACUTE DECOMPENSATED HEART FAILURE: EVIDENCE FOR A SELECTIVE AND RELATIVE ATRIAL NATRIURETIC PEPTIDE DEFICIENCY 50
Bisphosphonate-associated femoral fracture: Implications for management 49
Association of NPPA rs5065 Genetic Variant With Increased Cardiovascular Risk in the General USA Population 48
Hypokalemic rhabdomyolysis in a patient with a laparoscopic adjustable gastric banding 46
The BNP genetic variant rs198389: cardiovascular phenotype and risk in stage A/B heart failure subjects from the STOP-HF Trial 46
Aging and oral health: Effects in hard and soft tissues 46
Aldosterone, Cardiorenal and Metabolic Disease in a General Community in Olmsted County, Minnesota: Biomarker and/or Mediator 46
The Anp genetic variant Rs5068 and circulating levels of natriuretic peptides in patients with chronic heart failure 45
Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: A 9-year follow-up study 43
Differential Regulation of ANP and BNP in Acute Decompensated Heart Failure: Deficiency of ANP 43
A cardio-metabolic phenotype in carriers of NPPA (rs5086) and NPPB (rs198389) gene variants in the general population: the dominant role of ANP 42
MANP: A Novel Designer Natriuretic Peptide for Cardiometabolic Disease 42
A cardiometabolic protective phenotype associated with the ANP genetic variant rs5068 in African Americans: the Multi-Ethnic Study of Atherosclerosis (MESA) 42
FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa 41
Metabolic disease in the general population: a potential cyclic GMP deficiency states 41
Circulating aldosterone predicts future cardiorenal and metabolic disease in the general community 41
Aldosterone in the General Community: Biomarker or Mediator of Cardiorenal and Metabolic Disease 41
CHARACTERIZATION OF ANP GENETIC VARIANT RS5068 IN CHRONIC HEART FAILURE PATIENTS 40
Aldosterone Level in the General Community Predicts New Onset Cardiometabolic Disease 38
THE BNP GENETIC VARIANT RS198389: HYPERTENSION RISK AND CARDIOVASCULAR PHENOTYPE IN STAGE A AND STAGE B HEART FAILURE SUBJECTS FROM THE STOP-HF TRIAL 38
An update on rickettsiosis 38
Circulating cGMP Levels in the General Population: Relationship with Cardiovascular and Renal Diseases 37
The ANP Genetic Variant rs5068 Is Associated with Higher Circulating Concentrations of Natriuretic Peptides in Patients with Chronic Heart Failure 37
Can a cardiac peptide predict mortality in human hypertension? 37
A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community 36
Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population 36
Aldosterone predicts cardiovascular, renal, and metabolic disease in the general community: A 4-year follow-up 36
Chronic Renal Insufficiency: Prevalence in the General Population and Improved Detection of Cardiac Disease in Combination with BNP Assays 36
Plasma Aldosterone and Heart Failure in the General Community 35
Aldosterone: Marker and Predictor of Cardiorenal and Metabolic Disease in the General Community 35
A favorable cardiometabolic profile is associated with the G allele of the genetic variant rs5068 in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA) 34
Mineral bone diseases and thermal walter therapy hot mud bath 34
The atrial natriuretic peptide genetic ariant rs5068 is associated with a favorable cardiometabolic phenotype in a mediterranean population 34
IN-DEPTH PHENOTYPE OF SUBJECTS WITH INCREASED HEART FAILURE RISK BASED ON B-TYPE NATRIURETIC PEPTIDE 34
A Genetic Variant of the ANP Gene Is Associated With a Lower Cardiometabolic Risk Profile in the General USA Population 33
Circulating aldosterone and natriuretic peptides in the general community relationship to cardiorenal and metabolic disease 32
MANP: A novel designer natriuretic peptide GC-A activator for the treatment of hypertension and heart failure 32
An atrial natriuretic peptide genetic variant (rs5065) in the general US population identifies risk for cerebrovascular accidents 32
The malnutrition in the elderly: A clinical approach 31
Insulin/glucose induces natriuretic peptide clearance receptor in human adipocytes: A metabolic link with the cardiac natriuretic pathway 31
Evidence for a Prehypertensive Water Dysregulation Affecting the Development of Hypertension: Results of Very Early Treatment of Vasopressin V1 and V2 Antagonism in Spontaneously Hypertensive Rats 30
Circulating cGMP plasma levels in cardiovascular and renal diseases: new insights from the general community 30
The Soluble Guanylate Cyclase Genetic Variant rs13139571 Is Associated with an “Unfavorable” Metabolic Phenotype in an US General Community 30
Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis) 29
Metformin-induced lactic acidosis in a type 2 diabetic patient with acute renal failure 28
In Vitro and In Vivo Actions of a Novel ANP Genetic Variant: Unique Actions on Human Endothelial Cells 28
A genetic variant of the NPPA gene (rs5068) is associated with increased NT-ANP levels and reduced cardiometabolic risk 27
Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolism 24
A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure 23
Circulating molecular forms of ANP and BNP in human acute decompensated heart failure: evidence for a relative ANP deficiency state 21
The role of OPG, RANK, RANKL in the bone metabolism, cardiovascular disease and immune system: Clinical and physiopathological implication 21
Necrotizing fasciitis of the face: A life-threatening condition 20
Evidence of autonomic dysregulation in otherwise healthy cancer caregivers: A possible link with health hazard 20
Circulating Corin in the General Community: A Link to Gender and Metabolic Phenotype 17
STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart Failure 15
Circulating corin in the general community: link to gender and metabolic dysfunction 15
Natriuretic Peptides and Blood Pressure Homeostasis: Implications for MANP, a Novel Guanylyl Cyclase a Receptor Activator for Hypertension 14
First-in-Human Study of MANP: A Novel ANP (Atrial Natriuretic Peptide) Analog in Human Hypertension 13
Natriuretic peptide pathways in heart failure: further therapeutic possibilities 8
Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation 5
Totale 2.477
Categoria #
all - tutte 11.714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.714


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020582 122 133 19 2 16 88 44 40 38 46 26 8
2020/2021128 13 6 7 16 3 13 10 11 26 5 10 8
2021/2022224 7 7 4 4 7 2 17 28 11 13 9 115
2022/2023962 109 87 20 72 94 87 7 89 341 2 31 23
2023/2024353 29 34 14 13 41 71 16 34 17 22 31 31
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 2.477